Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Journal of invasive cardiology

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 24184894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supplemental Table 1

  2016cited by this paper
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

  2013cited by this paper
• Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.

  2012cited by this paper
• The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome.

  2012cited by this paper
• Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design

  2011cited by this paper
• A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.

  2011cited by this paper
• Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients.

  2011cited by this paper
• Arteriotomy Closure Devices for Cardiovascular Procedures: A Scientific Statement From the American Heart Association

  2010cited by this paper
• A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor

  2008cited by this paper
• Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

  2007cited by this paper
• Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry

  2007cited by this paper
• Bivalirudin for patients with acute coronary syndromes.

  2006cited by this paper
• Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.

  2005cited by this paper
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

  2004cited by this paper
• Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

  2003cited by this paper

• Aptamer-functionalized Hydrogels for the Programmable Release of Growth Factors

  2014cites this paper